Folic acid oversupplementation during pregnancy disorders lipid metabolism in male offspring via regulating arginase 1-associated NOS3-AMPKα pathway

Clin Nutr. 2022 Jan;41(1):21-32. doi: 10.1016/j.clnu.2021.11.004. Epub 2021 Nov 10.

Abstract

Background & aims: Folic acid supplementation is widely accepted during pregnancy, as it exerts a protective effect on neural tube defects. However, the long-term underlying effects of folic acid supplementation during pregnancy (FASDP) on offspring remain unclear.

Methods: Thirty pregnant female rats were randomly divided into normal control group, folic acid appropriate supplementation group (2.5 × FA group) and folic acid oversupplementation group (5 × FA group) and fed with corresponding folic acid concentration AIN93G diet. UPLC-Q-TOF-MS, UPLC-TQ-MS and GC-MS were performed to detect the serum metabolites profiles in adult male offspring and explore the effects of FASDP. Moreover, molecular biology technologies were used to clarify the underlying mechanism.

Results: We demonstrate that 2.5-folds folic acid leads to dyslipidemic-diabetic slightly in male offspring, while 5-folds folic acid aggravates the disorder and prominent hepatic lipid accumulations. Using untargeted and targeted metabolomics, total 63 differential metabolites and 12 significantly differential KEGG pathways are identified. Of note, arginine biosynthesis, arginine and proline metabolism are the two most significant pathways. Mechanistic investigations reveal that the increased levels of arginase-1 (Arg1) causes the lipid metabolism disorder by regulating nitric oxide synthase-3 (NOS3)-adenosine monophosphate activated protein kinase-α (AMPKα) pathway, resulting in lipid accumulation in hepatocytes.

Conclusions: Our data suggest that maternal folic acid oversupplementation during pregnancy contributes to lipid metabolism disorder in male offspring by regulating Arg1-NOS3-AMPKα pathway.

Keywords: Arginase; Folic acid supplementation; Gestational nutrition; Lipid metabolism; Metabolomics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AMP-Activated Protein Kinases / metabolism
  • Animals
  • Arginase / metabolism*
  • Diet / methods
  • Dietary Supplements / adverse effects*
  • Female
  • Folic Acid / administration & dosage
  • Folic Acid / adverse effects*
  • Gas Chromatography-Mass Spectrometry
  • Hepatocytes / metabolism
  • Lipid Metabolism / drug effects
  • Lipid Metabolism Disorders / chemically induced*
  • Liver / metabolism
  • Male
  • Metabolomics
  • Nitric Oxide Synthase Type III / metabolism
  • Pregnancy
  • Prenatal Exposure Delayed Effects / chemically induced*
  • Rats
  • Signal Transduction / drug effects

Substances

  • Folic Acid
  • Nitric Oxide Synthase Type III
  • Nos3 protein, rat
  • AMP-Activated Protein Kinases
  • Arginase